Surveillance of invasive bacterial disease in Alaska, 2003

The Centers for Disease Control and Prevention's Arctic Investigations Program (AIP) in Anchorage, Alaska, maintains a statewide surveillance system for invasive diseases caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and groups A and B streptococci. Laborat...

Full description

Bibliographic Details
Other Authors: National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Division of Preparedness and Emerging Infections. Arctic Investigations Program.
Language:English
Subjects:
Online Access:http://stacks.cdc.gov/view/cdc/43845/
id ftcdc:oai:example.org:cdc:43845
record_format openpolar
spelling ftcdc:oai:example.org:cdc:43845 2023-05-15T15:09:32+02:00 Surveillance of invasive bacterial disease in Alaska, 2003 National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Division of Preparedness and Emerging Infections. Arctic Investigations Program. Alaska 32 numbered pages http://stacks.cdc.gov/view/cdc/43845/ eng eng cdc:43845 http://stacks.cdc.gov/view/cdc/43845/ Bacterial Infections Disease Notification Haemophilus Influenzae Neisseria Meningitidis Pneumococcal Infections Public Health Surveillance Streptococcal Infections ftcdc 2017-04-11T13:40:03Z The Centers for Disease Control and Prevention's Arctic Investigations Program (AIP) in Anchorage, Alaska, maintains a statewide surveillance system for invasive diseases caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and groups A and B streptococci. Laboratories throughout the state are requested to send to AIP any isolates of these organisms recovered from a blood culture, CSF, or other normally sterile site. Isolate identification is confirmed and, when appropriate, serotyped and tested for antimicrobial susceptibility. The objectives of this system are to provide information on disease rates within the state, monitor the emergence of antimicrobial resistance, and to monitor the effectiveness of implemented vaccine programs, such as the 23-valent pneumococcal polysaccharide vaccine, the 7-valent pneumococcal conjugate vaccine and Haemophilus influenzae type b vaccines. In 2003, the total number of cases of invasive disease caused by these organisms reported to AIP were 98 S. pneumoniae, 18 H. influenzae, 4 N. meningitidis, 23 group A strep and 20 group B strep. Alaska Native populations had higher rates of disease than non-Native populations in all invasive disease except those caused by Group B streptococcus. Rates of invasive pneumococcal disease were highest in Norton Sound; H. influenzae rates were highest in YK Delta. Summary -- Introduction -- Invasive Pneumococcal Disease -- Invasive Haemophilus influenzae -- Invasive Neisseria meningitidis -- Invasive Group A Streptococcus -- Invasive Group B Streptococcus -- References -- Appendix: MIC Interpretive Standards Definitions. Other/Unknown Material Arctic Alaska CDC Stacks (Centers for Disease Control and Prevention) Anchorage Arctic Norton Sound ENVELOPE(69.507,69.507,-49.202,-49.202)
institution Open Polar
collection CDC Stacks (Centers for Disease Control and Prevention)
op_collection_id ftcdc
language English
topic Bacterial Infections
Disease Notification
Haemophilus Influenzae
Neisseria Meningitidis
Pneumococcal Infections
Public Health Surveillance
Streptococcal Infections
spellingShingle Bacterial Infections
Disease Notification
Haemophilus Influenzae
Neisseria Meningitidis
Pneumococcal Infections
Public Health Surveillance
Streptococcal Infections
Surveillance of invasive bacterial disease in Alaska, 2003
topic_facet Bacterial Infections
Disease Notification
Haemophilus Influenzae
Neisseria Meningitidis
Pneumococcal Infections
Public Health Surveillance
Streptococcal Infections
description The Centers for Disease Control and Prevention's Arctic Investigations Program (AIP) in Anchorage, Alaska, maintains a statewide surveillance system for invasive diseases caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and groups A and B streptococci. Laboratories throughout the state are requested to send to AIP any isolates of these organisms recovered from a blood culture, CSF, or other normally sterile site. Isolate identification is confirmed and, when appropriate, serotyped and tested for antimicrobial susceptibility. The objectives of this system are to provide information on disease rates within the state, monitor the emergence of antimicrobial resistance, and to monitor the effectiveness of implemented vaccine programs, such as the 23-valent pneumococcal polysaccharide vaccine, the 7-valent pneumococcal conjugate vaccine and Haemophilus influenzae type b vaccines. In 2003, the total number of cases of invasive disease caused by these organisms reported to AIP were 98 S. pneumoniae, 18 H. influenzae, 4 N. meningitidis, 23 group A strep and 20 group B strep. Alaska Native populations had higher rates of disease than non-Native populations in all invasive disease except those caused by Group B streptococcus. Rates of invasive pneumococcal disease were highest in Norton Sound; H. influenzae rates were highest in YK Delta. Summary -- Introduction -- Invasive Pneumococcal Disease -- Invasive Haemophilus influenzae -- Invasive Neisseria meningitidis -- Invasive Group A Streptococcus -- Invasive Group B Streptococcus -- References -- Appendix: MIC Interpretive Standards Definitions.
author2 National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Division of Preparedness and Emerging Infections. Arctic Investigations Program.
title Surveillance of invasive bacterial disease in Alaska, 2003
title_short Surveillance of invasive bacterial disease in Alaska, 2003
title_full Surveillance of invasive bacterial disease in Alaska, 2003
title_fullStr Surveillance of invasive bacterial disease in Alaska, 2003
title_full_unstemmed Surveillance of invasive bacterial disease in Alaska, 2003
title_sort surveillance of invasive bacterial disease in alaska, 2003
url http://stacks.cdc.gov/view/cdc/43845/
op_coverage Alaska
long_lat ENVELOPE(69.507,69.507,-49.202,-49.202)
geographic Anchorage
Arctic
Norton Sound
geographic_facet Anchorage
Arctic
Norton Sound
genre Arctic
Alaska
genre_facet Arctic
Alaska
op_relation cdc:43845
http://stacks.cdc.gov/view/cdc/43845/
_version_ 1766340715661492224